How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention
How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention
复制标题
DOI：
10.1093/jnci/djaa089
复制
发表时间：
2021-06-01
影响因子：
10.3
通讯作者：
Haas, Jennifer S.
中科院分区：
文献类型：
--
作者：
Feldman, Sarah;Haas, Jennifer S.
过去几个月的2019冠状病毒病（COVID-2019）大流行给了我们充分的机会来反思美国的医疗保健系统。尽管有压倒性的悲剧，但这是我们学习和改变的机会。由于大流行，我们推迟了例行检查，我们担心推迟癌症筛查的患者面临的风险。我们以宫颈癌筛查和预防为例，说明我们如何利用从大流行中吸取的一些“教训”来防止“附带损失”，如癌症的增加。与2019冠状病毒病相关的卫生系统变化，如诊断测试和疫苗的更快速评估，大多数咨询和教育访问向补偿虚拟护理的过渡，以及扩大家庭服务的可及性，为提供宫颈癌筛查和预防提供了潜在的好处。虽然我们详细介绍了宫颈癌预防的情况，但讨论的许多问题都可以推广到其他预防措施。如果2019年COVID的发病率和死亡率因延迟或推迟癌症筛查和诊断评估造成的额外痛苦而成倍增加，那将是一场悲剧-但也许通过创造力和反思，我们可以利用这场大流行病来改善护理。
These past months of the coronavirus disease-2019 (COVID-2019) pandemic have given us ample opportunity to reflect on the US health-care system. Despite overwhelming tragedy, it is an opportunity for us to learn and to change. As we postpone routine visits because of the pandemic, we worry about risks for patients who delay cancer screening. We use cervical cancer screening and prevention as an example of how we can use some "lessons learned" from the pandemic to prevent "collateral losses," such as an increase in cancers. COVID-2019-related health-system changes, like the more rapid evaluation of diagnostic tests and vaccines, the transition to compensated virtual care for most counseling and education visits, and broadened access to home services, offer potential benefits to the delivery of cervical cancer screening and prevention. While we detail the case for cervical cancer prevention, many of the issues discussed are generalizable to other preventative measures. It would be a tragedy if the morbidity and mortality of COVID-2019 are multiplied because of additional suffering caused by delayed or deferred cancer screening and diagnostic evaluation-but maybe with creativity and reflection, we can use this pandemic to improve care.